Frequency and plans for auditing trial conduct
The Investigator will assure that the study staff cooperate with monitoring and audits. The Investigator agrees to allow auditing of all essential clinical study documents by the FDA or other appropriate regulatory authorities. Auditing visits will be scheduled with the appropriate staff at mutually agreeable times as applicable.